Beijing Geekgene Technology Co., Ltd

This is a very early study to check the safety and initial effects of an experimental cell therapy called GK01. It will involve 10 adults with advanced solid tumors that have progressed despite standard treatments. The main goal is to see if the treatment is safe and how the body…

This early-stage study is testing a new cell therapy called GK01 in patients with advanced solid tumors who have run out of standard treatment options. Researchers will give 15 participants injections of their own modified immune cells to see if the treatment is safe and what dos…